{"symbol":"ABT","fiscalQuarter":"Q3-2023","reportDate":"2023-10-18","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2023","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Up 3.71%","keyNumbers":[{"metric":"EPS","actual":"$1.14","expected":"N/A","surprise":"+3.45%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an earnings per share of $1.14, exceeding expectations slightly. The stock reacted positively, rising 3.71%, likely reflecting investor confidence in the company's performance despite the absence of revenue data and guidance. The lack of additional commentary from management leaves some uncertainty about future directions.","metaDescription":"Abbott Laboratories (ABT) Q3 2023 earnings: EPS beat by 3.45%. Stock up 3.71%. Full breakdown."}}